FETSCH, T

Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial

FETSCH, T. (2004) · European Heart Journal

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments

Cited by 334

Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial

Goette, A., Schön, N., Kirchhof, P., Breithardt, G., Fetsch, T., Häusler, K. G., Klein, H. U., Steinbeck, G., Wegscheider, K., & Meinertz, T. (2012) · Circulation Arrhythmia and Electrophysiology

Atrial Fibrillation Management and OutcomesCardiac electrophysiology and arrhythmias

Cited by 187

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference

Kirchhof, P., Breithardt, G., Aliot, E., Al Khatib, S., Apostolakis, S., Auricchio, A., Bailleul, C., Bax, J., Benninger, G., Blomstrom-Lundqvist, C., et al. (2013) · Europace

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and Treatments

Cited by 141